BACKGROUND: Cardiovascular disease is an important cause of death in patients with end-stage renal disease. Although coronary artery bypass graft (CABG) surgery and drug-eluting stent (DES) implantation have been compared in chronic hemodialysis patients, the results are unclear. METHODS: The study population consisted of chronic hemodialysis patients (dialysis duration >6 months) with coronary artery disease who underwent DES implantation or CABG at the Asan Medical Center (Seoul, Korea) between January 1, 2003, and February 28, 2006. We followed them until December, 2012. The mean follow-up was 50.91 ± 31.86 months for DES patients and 50.63 ± 36.43 months for CABG patients. Primary end points were major adverse cardiac and cerebral events (MACCE). Propensity-score matching was used to reduce selection bias and variable characteristics. RESULTS: Of 87 chronic hemodialysis patients with coronary artery disease, 44 underwent DES implantation and 43 underwent CABG surgery. Multivessel disease patients were 70.45 % in the DES group and 95.35 % in the CABG group. After propensity score adjustment, the MACCE-free survival was significantly higher in the CABG group than in the DES group (HR 3.265; 95 % CI 1.357-7.858; p = 0.008), but overall survival did not differ between the groups (HR 0.968; 95 % CI 0.267-3.507; p = 0.960). CONCLUSION: We found that, compared with DES, CABG showed significantly better MACCE-free survival in chronic hemodialysis patients.
BACKGROUND:Cardiovascular disease is an important cause of death in patients with end-stage renal disease. Although coronary artery bypass graft (CABG) surgery and drug-eluting stent (DES) implantation have been compared in chronic hemodialysis patients, the results are unclear. METHODS: The study population consisted of chronic hemodialysis patients (dialysis duration >6 months) with coronary artery disease who underwent DES implantation or CABG at the Asan Medical Center (Seoul, Korea) between January 1, 2003, and February 28, 2006. We followed them until December, 2012. The mean follow-up was 50.91 ± 31.86 months for DES patients and 50.63 ± 36.43 months for CABG patients. Primary end points were major adverse cardiac and cerebral events (MACCE). Propensity-score matching was used to reduce selection bias and variable characteristics. RESULTS: Of 87 chronic hemodialysis patients with coronary artery disease, 44 underwent DES implantation and 43 underwent CABG surgery. Multivessel diseasepatients were 70.45 % in the DES group and 95.35 % in the CABG group. After propensity score adjustment, the MACCE-free survival was significantly higher in the CABG group than in the DES group (HR 3.265; 95 % CI 1.357-7.858; p = 0.008), but overall survival did not differ between the groups (HR 0.968; 95 % CI 0.267-3.507; p = 0.960). CONCLUSION: We found that, compared with DES, CABG showed significantly better MACCE-free survival in chronic hemodialysis patients.
Authors: William Wijns; Philippe Kolh; Nicolas Danchin; Carlo Di Mario; Volkmar Falk; Thierry Folliguet; Scot Garg; Kurt Huber; Stefan James; Juhani Knuuti; Jose Lopez-Sendon; Jean Marco; Lorenzo Menicanti; Miodrag Ostojic; Massimo F Piepoli; Charles Pirlet; Jose L Pomar; Nicolaus Reifart; Flavio L Ribichini; Martin J Schalij; Paul Sergeant; Patrick W Serruys; Sigmund Silber; Miguel Sousa Uva; David Taggart Journal: Eur Heart J Date: 2010-08-29 Impact factor: 29.983
Authors: Edward L Hannan; Michael J Racz; Gary Walford; Robert H Jones; Thomas J Ryan; Edward Bennett; Alfred T Culliford; O Wayne Isom; Jeffrey P Gold; Eric A Rose Journal: N Engl J Med Date: 2005-05-26 Impact factor: 91.245
Authors: Arie Pieter Kappetein; Stuart J Head; Marie-Claude Morice; Adrian P Banning; Patrick W Serruys; Friedrich-Wilhelm Mohr; Keith D Dawkins; Michael J Mack Journal: Eur J Cardiothorac Surg Date: 2013-02-14 Impact factor: 4.191
Authors: D A Morrison; G Sethi; J Sacks; W Henderson; F Grover; S Sedlis; R Esposito; K Ramanathan; D Weiman; J Saucedo; T Antakli; V Paramesh; S Pett; S Vernon; V Birjiniuk; F Welt; M Krucoff; W Wolfe; J C Lucke; S Mediratta; D Booth; C Barbiere; D Lewis Journal: J Am Coll Cardiol Date: 2001-07 Impact factor: 24.094
Authors: Edward L Hannan; Chuntao Wu; Gary Walford; Alfred T Culliford; Jeffrey P Gold; Craig R Smith; Robert S D Higgins; Russell E Carlson; Robert H Jones Journal: N Engl J Med Date: 2008-01-24 Impact factor: 91.245
Authors: Patrick W Serruys; Marie-Claude Morice; A Pieter Kappetein; Antonio Colombo; David R Holmes; Michael J Mack; Elisabeth Ståhle; Ted E Feldman; Marcel van den Brand; Eric J Bass; Nic Van Dyck; Katrin Leadley; Keith D Dawkins; Friedrich W Mohr Journal: N Engl J Med Date: 2009-02-18 Impact factor: 91.245
Authors: Alfredo E Rodriguez; Andrew O Maree; Juan Mieres; Daniel Berrocal; Liliana Grinfeld; Carlos Fernandez-Pereira; Valeria Curotto; Alfredo Rodriguez-Granillo; William O'Neill; Igor F Palacios Journal: Eur Heart J Date: 2007-07-25 Impact factor: 29.983